Clearmind Medicine Inc. (CMND) vs GlucoTrack, Inc. (GCTK)

A side-by-side comparison of Clearmind Medicine Inc. and GlucoTrack, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Clearmind Medicine Inc. logo
CMND
Clearmind Medicine Inc.
$1M
$5.78HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
GlucoTrack, Inc. logo
GCTK
GlucoTrack, Inc.
$873967
$1.10HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT

Total return — CMND vs GCTK

growth of $100 · dividends reinvested · last 4y
CMND -100.0% (-94.3%/yr)GCTK -100.0% (-94.8%/yr)CMND compounded faster over this window
050100150Start $1002023202420252026$0$0
CMND GCTK

CMND vs GCTK: by the numbers

  • •CMND is the larger company ($1M vs $873967 market cap).

Metrics side by side

Valuation

MetricCMNDGCTK
P/B ratio0.08N/A

Profitability

MetricCMNDGCTK
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-57.87%N/A
ROIC-60.41%N/A

Growth (annualized)

MetricCMNDGCTK
Total return CAGR (5Y)N/A-92.60%

Go deeper

Full CMND analysisFull GCTK analysisInteractive comparison tool

Dig into the metrics

Clearmind Medicine ROEGlucoTrack ROEClearmind Medicine operating marginGlucoTrack operating marginClearmind Medicine revenue growthGlucoTrack revenue growthClearmind Medicine free cash flowGlucoTrack free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.